AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway

  • Authors:
    • Hailiang Xu
    • Yunyun Feng
    • Zhankui Jia
    • Jinjian Yang
    • Xueren Lu
    • Jun Li
    • Mingliang Xia
    • Chunru Wu
    • Yonggang Zhang
    • Jianhua Chen
  • View Affiliations

  • Published online on: May 19, 2017     https://doi.org/10.3892/ol.2017.6214
  • Pages: 981-986
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Axis inhibition protein 1 (AXIN1) is characterized as a tumor suppressor in numerous types of cancer. However, the functional role of AXIN1 in the testicular germ cell tumors (TGCTs) remains unclear. The human embryonal carcinoma-derived cell line NTera2 was transfected with a recombinant AXIN1 expression vector (pcDNA3.1‑AXIN1) and/or a small interfering RNA (siRNA) directed against AXIN1 (siAXIN). Following transfection, the mRNA and protein levels of AXIN1 were determined via reverse transcription‑quantitative polymerase chain reaction analysis and western blotting, respectively. In addition, cell viability, apoptosis and the expression of apoptosis‑associated proteins [apoptosis regulator Bax (Bax) and B‑cell lymphoma (Bcl)‑2] and phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway proteins [phosphorylated (p)‑mTOR, mTOR, p‑AKT, AKT, P‑70S ribosomal protein S6 (S6) and S6] were assessed. AXIN1 mRNA and protein levels were increased following transfection with pcDNA3.1‑AXIN1 and decreased following transfection with siAXIN1 compared with their respective control groups. After overexpression of AXIN1, NTera2 cell viability and expression of Bcl‑2, p‑mTOR p‑AKT and p‑S6 protein was decreased, while apoptosis and Bax protein levels were increased, compared with the control group. However, there was no significant difference in AXIN1 mRNA expression, apoptosis or Bax/Bcl‑2 protein expression when NTera2 cells were simultaneously transfected with pcDNA3.1‑AXIN1+siAXIN1. In conclusion, the results of the present study indicate that overexpression of AXIN1 protects against TGCTs via inhibiting the PI3K/AKT/mTOR signaling pathway, suggesting that AXIN1 may be a potential target for gene therapy in TGCTs.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu H, Feng Y, Jia Z, Yang J, Lu X, Li J, Xia M, Wu C, Zhang Y, Chen J, Chen J, et al: AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway. Oncol Lett 14: 981-986, 2017
APA
Xu, H., Feng, Y., Jia, Z., Yang, J., Lu, X., Li, J. ... Chen, J. (2017). AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway. Oncology Letters, 14, 981-986. https://doi.org/10.3892/ol.2017.6214
MLA
Xu, H., Feng, Y., Jia, Z., Yang, J., Lu, X., Li, J., Xia, M., Wu, C., Zhang, Y., Chen, J."AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway". Oncology Letters 14.1 (2017): 981-986.
Chicago
Xu, H., Feng, Y., Jia, Z., Yang, J., Lu, X., Li, J., Xia, M., Wu, C., Zhang, Y., Chen, J."AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway". Oncology Letters 14, no. 1 (2017): 981-986. https://doi.org/10.3892/ol.2017.6214